Salesforce (NYSE:CRM | CRM Price Prediction) currently trades at $173.79, while the average Wall Street price target sits at $245.16. That is roughly a 41% implied upside gap.
Salesforce is the world’s largest customer relationship management software provider, repositioning itself around Agentforce, its platform for deploying autonomous AI agents inside enterprise sales, service, and marketing workflows. The AI monetization thesis is either real or it is not, and the 2026 selloff has forced the question.
Analysts have not backed off. Wedbush’s Dan Ives carries a $475 price target that implies roughly 173% upside from here.
A 34% Drawdown in a Rising Market
CRM is down 34.05% year to date while the S&P 500 has gained 8.82%. That is violent underperformance for a mega-cap software name despite visibly improving fundamentals.
The catalyst was a slow-motion sector derating. IBM’s July warning about customers reallocating IT budgets toward AI infrastructure was described as a “hammer” slamming down on tech’s AI outsiders, with CRM named directly alongside ServiceNow. The fear is that enterprises are cutting seats on traditional application software to fund GPU spend, putting Salesforce squarely in the crosshairs.
The drawdown is strange given the earnings picture. Q1 FY27 delivered EPS of $3.88 against a $3.13 consensus, revenue of $11.13 billion up 13.3% YoY, and marked the fifth straight quarterly EPS beat. The market sold it anyway.
Why Ives and the Bulls Refuse to Blink
The core bull thesis is that Agentforce represents a new subscription tier. Agentforce ARR hit $1.2 billion in Q1 FY27, up 205% YoY, and combined Agentforce plus Data 360 ARR reached roughly $3.4 billion, growing over 200% YoY.
Wedbush’s Dan Ives builds his $475 target on three pillars: Agentforce monetization as a structural upgrade cycle with fully autonomous agents driving high-margin ARR expansion; an unrivaled data moat through Data Cloud, where enterprises are forced to centralize customer data inside Salesforce to make agents functional; and margin expansion combined with re-accelerating growth, arguing the market underestimates how much AI upsell revenue will drop to free cash flow after cost discipline and the $25 billion accelerated buyback that shrank the share count.
Consensus ratings back the direction. Analysts split 6 Strong Buy, 34 Buy, 10 Hold, 0 Sell, and 2 Strong Sell. Management raised FY27 revenue guidance to $45.9 to $46.2 billion and set a $63 billion FY30 revenue target. Insider activity has skewed toward buying, with 55 recent insider transactions net positive. Analyst targets show reiterations and raises, not cuts.
The Software Group Got Hit, But CRM Fell Hardest Among the Cheap Names
ServiceNow (NYSE:NOW) is down 31.65% YTD at $104.70, versus a $141.64 average target for roughly 35% upside. Wall Street is bullish (9 Strong Buy, 34 Buy, 4 Hold, 1 Sell), but the multiple stays rich and the AI-capex-crowding-out story hangs over next quarter’s earnings report.
Oracle (NYSE:ORCL) is the outlier. Shares sit at $121.38, down 37.12% YTD, against a $251.85 target implying more than 107% upside. Ratings tilt heavily bullish (8 Strong Buy, 29 Buy, 5 Hold, 1 Sell), but AI-driven capex has turned free cash flow deeply negative.
HubSpot (NYSE:HUBS) trades at $231.26, off 42.38% YTD, with a $275.72 target and modest 19% upside. Recent revisions have skewed negative, including a Wells Fargo downgrade to Equal Weight with a cut from $300 to $225.
The largest analyst-implied upside in this group sits with Oracle on consensus, but CRM’s $475 high-water target is the boldest single call. This is a group derating, and Salesforce has the widest range between consensus and the most bullish voice.
What the Stock Actually Says About Salesforce
CRM sits at $173.79 with a consensus target of $245.16, an implied upside of roughly 41%, drawn from a coverage universe of 52 analysts. Trailing P/E is 20x and forward P/E is 13x, unusually cheap for a name growing revenue in the low double digits with 77% gross margins.
Year to date the stock is down 34.05% against the S&P 500’s gain of 8.82%. Over the last month, CRM has clawed back 14.5% while the index slipped 0.62%, hinting that capitulation may be finished.
Where I Land on Salesforce at $173
The bull case works if you believe Agentforce is a real product cycle rather than a marketing wrapper. The fundamentals support that read: five straight EPS beats, ARR compounding at triple digits, buybacks shrinking the float, and a forward P/E in the low teens. The path back to $245 is Agentforce ARR crossing $2 billion, current RPO growth staying in the mid-teens, and one clean quarter that puts the IBM-warning fears to bed.
The bear case works if you think the IBM thesis is correct and enterprises are reallocating software budgets toward GPUs and hyperscaler consumption. In that world, seat-based CRM revenue stalls, Agentforce cannibalizes rather than expands, and the $39.3 billion in noncurrent debt from the buyback becomes a real drag on multiple.
My lean is cautiously long. Ives’ $475 target is aggressive, but consensus at $245 looks reachable inside 12 months if management delivers promised H2 FY27 acceleration. The risk/reward at 13x forward earnings with 200%+ ARR growth in the AI segment is asymmetric enough to matter.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks